Marshall Wace’s Cimpress CMPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.73M Buy
36,654
+26,098
+247% +$2.32M ﹤0.01% 1516
2026
Q1
$771K Buy
+10,556
New +$780K ﹤0.01% 2254
2025
Q3
– Sell
-26,397
Closed -$1.24M – 2956
2025
Q2
$1.24M Buy
+26,397
New +$1.15M ﹤0.01% 1766
2024
Q3
– Sell
-107,350
Closed -$9.4M – 2562
2024
Q2
$9.4M Buy
107,350
+93,033
+650% +$8.11M 0.01% 757
2024
Q1
$1.27M Buy
14,317
+6,066
+74% +$515K ﹤0.01% 1552
2023
Q4
$660K Sell
8,251
-21,721
-72% -$1.51M ﹤0.01% 1614
2023
Q3
$2.1M Buy
+29,972
New +$1.98M ﹤0.01% 1202
2023
Q2
– Sell
-16,179
Closed -$709K – 2526
2023
Q1
$709K Sell
16,179
-44,584
-73% -$1.52M ﹤0.01% 1961
2022
Q4
$1.68M Buy
+60,763
New +$1.58M ﹤0.01% 1819
2020
Q4
– Sell
-6,489
Closed -$488K – 1914
2020
Q3
$488K Buy
+6,489
New +$556K ﹤0.01% 1256
2020
Q2
– Sell
-1,365
Closed -$73K – 1598
2020
Q1
$73K Buy
+1,365
New +$138K ﹤0.01% 1371
2016
Q3
– Sell
-4,800
Closed -$444K – 970
2016
Q2
$444K Buy
+4,800
New +$450K ﹤0.01% 847

Other funds holding CMPR

Marshall Wace's CMPR Position: Q2 2026 in Review

Marshall Wace increased its Cimpress (CMPR) stake by 247% in Q2 2026, buying an estimated $2.32M and bringing the position to 36,654 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Marshall Wace first reported a position in CMPR in Q2 2016 and has held it in 12 quarters since. The position peaked at $9.4M in Q2 2024. 211 funds tracked by Wall St. Rank hold CMPR as of Q2 2026.

  • Marshall Wace held 36,654 shares of Cimpress worth $3.73M as of Q2 2026.
  • Marshall Wace bought 26,098 Cimpress shares in Q2 2026, an estimated $2.32M.
  • Cimpress made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1516 holding.
  • Marshall Wace first reported a position in Cimpress in Q2 2016 and has held it in 12 quarters since.
  • Marshall Wace's Cimpress position peaked at $9.4M in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Cimpress as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.